Clinical Trial Detail

NCT ID NCT03691493
Title Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis (ASPIRE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Emory University
Indications

breast cancer

Therapies

Letrozole + Palbociclib

Palbociclib + Tamoxifen

Fulvestrant + Palbociclib

Anastrozole + Palbociclib

Exemestane + Palbociclib

Age Groups: adult senior

Additional content available in CKB BOOST